Tag Archive for: spin-off business

Due to safety concerns, Aristea Therapeutics announced Friday it is discontinuing the development of its Phase II lead program RIST4721. As a result, the San Diego-based biotech is also dissolving its business.

Novartis on Wednesday predicted that core operating income would grow in a “mid single digit” percentage range in 2023 following stagnation last year, as the Swiss drugmaker prepares to spin off its Sandoz generics business.

Laboratory Corp of America Holdings said it would spin off its wholly owned business focused on clinical drug trials. The planned spin-off will result in two independent, publicly traded companies – Labcorp and the clinical development business.